Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians. 2021;71:209– 49.
Dickstein DR, Lehrer EJ, Hsieh K, Hotca A, Jones BM, Powers A et al. Management of older adults with locally Advanced Head and Neck Cancer. Cancers (Basel). 2022;14.
Gormley M, Creaney G, Schache A, Ingarfield K, Conway DI. Reviewing the epidemiology of head and neck cancer: definitions, trends and risk factors. Br Dent J. 2022;233:780–6.
Gatta G, Capocaccia R, Botta L. Descriptive epidemiology of the head and neck cancers in old patients. Front Oncol. 2023;13.
National Comprehensive Cancer Network. Head and Neck Cancer (Version 2.2023). 2023.
Lacas B, Carmel A, Landais C, Wong SJ, Licitra L, Tobias JS et al. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 107 randomized trials and 19805 patients, on behalf of MACH-NC group. Radiother Oncol. 2021.
Rühle A, Marschner S, Haderlein M, Fabian A, Weymann M, Behrens M, et al. Evaluation of concomitant systemic treatment in older adults with Head and Neck squamous cell carcinoma undergoing definitive Radiotherapy. JAMA Netw Open. 2023;6:e230090–e.
Amini A, Jones BL, McDermott JD, Serracino HS, Jimeno A, Raben D, et al. Survival outcomes with concurrent chemoradiation for elderly patients with locally advanced head and neck cancer according to the National Cancer Data Base. Cancer. 2016;122:1533–43.
Rühle A, Haehl E, Kalckreuth T, Stoian R, Spohn SKB, Sprave T, et al. Surviving Elderly patients with Head-and-Neck squamous cell carcinoma—what is the long-term quality of life after curative Radiotherapy? Cancers. 2021;13:1275.
McDowell L, Rischin D, Gough K, Henson C. Health-Related Quality of Life, Psychosocial Distress and Unmet needs in older patients with Head and Neck Cancer. Front Oncol. 2022;12:834068.
Nutting CM, Morden JP, Harrington KJ, Urbano TG, Bhide SA, Clark C, et al. Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial. Lancet Oncol. 2011;12:127–36.
Nutting C, Finneran L, Roe J, Sydenham MA, Beasley M, Bhide S et al. Dysphagia-optimised intensity-modulated radiotherapy versus standard intensity-modulated radiotherapy in patients with head and neck cancer (DARS): a phase 3, multicentre, randomised, controlled trial. Lancet Oncol. 2023.
Li X, Kitpanit S, Lee A, Mah D, Sine K, Sherman EJ, et al. Toxicity profiles and survival outcomes among patients with nonmetastatic nasopharyngeal carcinoma treated with intensity-modulated Proton Therapy vs intensity-modulated Radiation Therapy. JAMA Netw Open. 2021;4:e2113205–e.
van der Laan HP, van de Water TA, van Herpt HE, Christianen ME, Bijl HP, Korevaar EW, et al. The potential of intensity-modulated proton radiotherapy to reduce swallowing dysfunction in the treatment of head and neck cancer: a planning comparative study. Acta Oncol. 2013;52:561–9.
Taylor KJ, Amdal CD, Bjordal K, Astrup GL, Herlofson BB, Duprez F et al. Serious Long-Term Effects of Head and Neck Cancer from the Survivors’ Point of View. Healthc (Basel). 2023;11.
Irune E, Dwivedi RC, Nutting CM, Harrington KJ. Treatment-related dysgeusia in head and neck cancer patients. Cancer Treat Rev. 2014;40:1106–17.
Stieb S, Mohamed ASR, Deshpande TS, Harp J, Greiner B, Garden AS, et al. Prospective observational evaluation of radiation-induced late taste impairment kinetics in oropharyngeal cancer patients: potential for improvement over time? Clin Translational Radiation Oncol. 2020;22:98–105.
Machtay M, Moughan J, Trotti A, Garden AS, Weber RS, Cooper JS, et al. Factors associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck cancer: an RTOG analysis. J Clin Oncol. 2008;26:3582–9.
Johansson A-K, Omar R, Mastrovito B, Sannevik J, Carlsson GE, Johansson A. Prediction of xerostomia in a 75-year-old population: a 25-year longitudinal study. J Dent. 2022;118:104056.
Doan TN, Ho WC, Wang LH, Chang FC, Nhu NT, Chou LW. Prevalence and Methods for Assessment of Oropharyngeal Dysphagia in older adults: a systematic review and Meta-analysis. J Clin Med. 2022;11.
Nakazato M, Endo S, Yoshimura I, Tomita H. Influence of aging on electrogustometry thresholds. Acta Otolaryngol Suppl. 2002:16–26.
Vandenberghe-Descamps M, Labouré H, Prot A, Septier C, Tournier C, Feron G, et al. Salivary Flow decreases in healthy Elderly people independently of Dental Status and Drug Intake. J Texture Stud. 2016;47:353–60.
Sommers L, van der Laan HP, Van den Bosch L, Hoek J, Zon-Meijer T, Oldehinkel E, et al. OC-0436 External validation of NTCP models for dysphagia and xerostomia in the elderly patients with HNSCC. Radiother Oncol. 2022;170:379–S80.
Beetz I, Schilstra C, van der Schaaf A, van den Heuvel ER, Doornaert P, van Luijk P, et al. NTCP models for patient-rated xerostomia and sticky saliva after treatment with intensity modulated radiotherapy for head and neck cancer: the role of dosimetric and clinical factors. Radiother Oncol. 2012;105:101–6.
Beetz I, Schilstra C, van Luijk P, Christianen MEMC, Doornaert P, Bijl HP, et al. External validation of three dimensional conformal radiotherapy based NTCP models for patient-rated xerostomia and sticky saliva among patients treated with intensity modulated radiotherapy. Radiother Oncol. 2012;105:94–100.
Van den Bosch L, van der Schaaf A, van der Laan HP, Hoebers FJP, Wijers OB, van den Hoek JGM, et al. Comprehensive toxicity risk profiling in radiation therapy for head and neck cancer: a new concept for individually optimised treatment. Radiother Oncol. 2021;157:147–54.
Samant P, Ruysscher Dd, Hoebers F, Canters R, Hall E, Nutting C et al. Machine learning for normal tissue complication probability prediction: predictive power with versatility and easy implementation. Clin Translational Radiation Oncol. 2023;39.
Grégoire V, Ang K, Budach W, Grau C, Hamoir M, Langendijk JA, et al. Delineation of the neck node levels for head and neck tumors: a 2013 update. DAHANCA, EORTC, HKNPCSG, NCIC CTG, NCRI, RTOG, TROG consensus guidelines. Radiother Oncol. 2014;110:172–81.
Grégoire V, Daisne JF, Geets X, Levendag P. Selection and delineation of target volumes in head and neck tumors: beyond ICRU definition. Rays. 2003;28:217–24.
Grégoire V, Evans M, Le QT, Bourhis J, Budach V, Chen A, et al. Delineation of the primary tumour clinical target volumes (CTV-P) in laryngeal, hypopharyngeal, oropharyngeal and oral cavity squamous cell carcinoma: AIRO, CACA, DAHANCA, EORTC, GEORCC, GORTEC, HKNPCSG, HNCIG, IAG-KHT, LPRHHT, NCIC CTG, NCRI, NRG Oncology, PHNS, SBRT, SOMERA, SRO, SSHNO, TROG consensus guidelines. Radiother Oncol. 2018;126:3–24.
van de Water TA, Bijl HP, Westerlaan HE, Langendijk JA. Delineation guidelines for organs at risk involved in radiation-induced salivary dysfunction and xerostomia. Radiother Oncol. 2009;93:545–52.
Christianen ME, Langendijk JA, Westerlaan HE, van de Water TA, Bijl HP. Delineation of organs at risk involved in swallowing for radiotherapy treatment planning. Radiother Oncol. 2011;101:394–402.
Brouwer CL, Steenbakkers RJHM, Bourhis J, Budach W, Grau C, Grégoire V, et al. CT-based delineation of organs at risk in the head and neck region: DAHANCA, EORTC, GORTEC, HKNPCSG, NCIC CTG, NCRI, NRG Oncology and TROG consensus guidelines. Radiother Oncol. 2015;117:83–90.
Vasquez Osorio E, Abravan A, Green A, van Herk M, Lee LW, Ganderton D et al. Dysphagia at 1 year is Associated with Mean dose to the Inferior section of the brain stem. Int J Radiat Oncol Biol Phys. 2023.
Hojin K, Jungwon K, Chiyoung J, Byungchul C. Institutional applications of Eclipse Scripting Programming Interface to Clinical workflows in Radiation Oncology. Prog Med Phys. 2017;28:122–8.
Van den Bosch L, Schuit E, van der Laan HP, Reitsma JB, Moons KGM, Steenbakkers RJHM, et al. Key challenges in normal tissue complication probability model development and validation: towards a comprehensive strategy. Radiother Oncol. 2020;148:151–6.
van Buuren S, Groothuis-Oudshoorn K. Mice: multivariate imputation by chained equations in R. J Stat Softw. 2011;45:1–67.
Stieb S, Lee A, van Dijk LV, Frank S, Fuller CD, Blanchard P. NTCP modeling of Late effects for Head and Neck Cancer: a systematic review. Int J Part Ther. 2021;8:95–107.
Ferguson DB, Botchway CA. Circadian variations in flow rate and composition of human stimulated submandibular saliva. Arch Oral Biol. 1979;24:433–7.
Ikeda M, Ikui A, Tomita H. Gustatory function of the soft palate. Acta Otolaryngol Suppl. 2002:69–73.
Russi EG, Corvò R, Merlotti A, Alterio D, Franco P, Pergolizzi S, et al. Swallowing dysfunction in head and neck cancer patients treated by radiotherapy: review and recommendations of the supportive task group of the Italian Association of Radiation Oncology. Cancer Treat Rev. 2012;38:1033–49.
Hedström J, Tuomi L, Finizia C, Olsson C. Identifying organs at risk for radiation-induced late dysphagia in head and neck cancer patients. Clin Translational Radiation Oncol. 2019;19:87–95.
Fried DV, Das SK, Shen C, Marks LB, Chera BS. Impact of oral cavity dosimetry on patient reported Xerostomia and Dysgeusia in the setting of Deintensified Chemoradiotherapy. Adv Radiat Oncol. 2022;7:100952.
Mazzola R, Ricchetti F, Fiorentino A, Fersino S, Giaj Levra N, Naccarato S, et al. Dose-volume-related dysphagia after constrictor muscles definition in head and neck cancer intensity-modulated radiation treatment. Br J Radiol. 2014;87:20140543.
Levendag PC, Teguh DN, Voet P, van der Est H, Noever I, de Kruijf WJ, et al. Dysphagia disorders in patients with cancer of the oropharynx are significantly affected by the radiation therapy dose to the superior and middle constrictor muscle: a dose-effect relationship. Radiother Oncol. 2007;85:64–73.
Mortensen HR, Jensen K, Aksglæde K, Behrens M, Grau C. Late dysphagia after IMRT for head and neck cancer and correlation with dose-volume parameters. Radiother Oncol. 2013;107:288–94.
Petkar I, Rooney K, Roe JWG, Patterson JM, Bernstein D, Tyler JM, et al. DARS: a phase III randomised multicentre study of dysphagia- optimised intensity- modulated radiotherapy (Do-IMRT) versus standard intensity- modulated radiotherapy (S-IMRT) in head and neck cancer. BMC Cancer. 2016;16:770.
Jensen K, Friborg J, Hansen CR, Samsøe E, Johansen J, Andersen M, et al. The Danish Head and Neck Cancer Group (DAHANCA) 2020 radiotherapy guidelines. Radiother Oncol. 2020;151:149–51.
Nutting CM, Morden JP, Beasley M, Bhide S, Cook A, De Winton E, et al. Results of a multicentre randomised controlled trial of cochlear-sparing intensity-modulated radiotherapy versus conventional radiotherapy in patients with parotid cancer (COSTAR; CRUK/08/004). Eur J Cancer. 2018;103:249–58.
Navran A, Heemsbergen W, Janssen T, Hamming-Vrieze O, Jonker M, Zuur C, et al. The impact of margin reduction on outcome and toxicity in head and neck cancer patients treated with image-guided volumetric modulated arc therapy (VMAT). Radiother Oncol. 2019;130:25–31.
Rühle A, Grosu A-L, Nicolay NH. De-escalation strategies of (Chemo)Radiation for Head-and-Neck squamous cell Cancers—HPV and Beyond. Cancers. 2021;13:2204.
Grégoire V, Grau C, Lapeyre M, Maingon P. Target volume selection and delineation (T and N) for primary radiation treatment of oral cavity, oropharyngeal, hypopharyngeal and laryngeal squamous cell carcinoma. Oral Oncol. 2018;87:131–7.
Biau J, Lapeyre M, Troussier I, Budach W, Giralt J, Grau C, et al. Selection of lymph node target volumes for definitive head and neck radiation therapy: a 2019 Update. Radiother Oncol. 2019;134:1–9.
Sher DJ, Adelstein DJ, Bajaj GK, Brizel DM, Cohen EEW, Halthore A, et al. Radiation therapy for oropharyngeal squamous cell carcinoma: executive summary of an ASTRO evidence-based clinical practice Guideline. Pract Radiat Oncol. 2017;7:246–53.
Koyfman SA, Ismaila N, Crook D, D’Cruz A, Rodriguez CP, Sher DJ, et al. Management of the Neck in squamous cell carcinoma of the oral cavity and oropharynx: ASCO Clinical Practice Guideline. J Clin Oncol. 2019;37:1753–74.
Meirovitz A, Murdoch-Kinch CA, Schipper M, Pan C, Eisbruch A. Grading xerostomia by physicians or by patients after intensity-modulated radiotherapy of head-and-neck cancer. Int J Radiation Oncology*Biology*Physics. 2006;66:445–53.
Add Comment